Dr. med. Klaus Rensing, MBA, FA

Dr. med. Klaus Rensing, MBA, FA has a diverse and extensive work experience spanning over several years. Dr. med. Klaus currently serves as the Head of Medical Affairs D/A/CH at Noscendo GmbH. In addition, they also work as a Trainer for ATMP-Courses.

Prior to their current roles, Dr. med. Klaus Rensing served as the Medical Director at Premier Healthcare Germany from 2018 to 2022. Before that, they worked as a Wissenschaftlicher Mitarbeiter/ Clinical Assessor at Paul-Ehrlich-Institut (PEI) from 2016 to 2018. Dr. med. Klaus also held the position of Medical Advisor Oncology at Berlin-Chemie AG/ MENARINI Group in 2015 and the role of Medical Therapeutic Area Lead Gyneco-Oncology at Roche Pharma AG in 2014.

Dr. med. Klaus Rensing's previous experience includes serving as the Executive Chief Medical Officer at Mubadala Healthcare - Healthpoint Hospital from 2011 to 2014. Before that, they held a managerial role as Leitung Center- & Clustermanagement/ KB Konzernentwicklung at Asklepios Kiniken Hamburg GmbH from 2009 to 2014. Dr. med. Klaus began their career as a Facharzt für Frauenheilkunde und Geburtshilfe - Koordinator des Brustzentrums Münster at the University of Muenster - Department of Gynecology & Obstetrics from 2000 to 2009. Dr. med. Klaus also worked as a Wissenschaftlicher Angestellter/Arzt in Weiterbildung Gynaekologie und Geburtshilfe at the University of Heidelberg - Department of Gynecology & Obstetrics from 1995 to 2000.

Dr. med. Klaus Rensing has an extensive education history. Dr. med. Klaus obtained their Vordiplom in Biologie; Physikum in Medizin from the University of Tübingen in 1988. Dr. med. Klaus then pursued their medical education at Heidelberg University from 1989 to 1995, earning a Dr. med./ Approbation als Arzt degree in Medicine.

During their time at Heidelberg University, Dr. Rensing also worked at the Deutsches Krebsforschungszentrum Heidelberg (DKFZ) from 1991 to 1995 and completed a PhD thesis, earning the degree of Promotion (M.D./ PhD-Thesis).

Dr. Rensing furthered their studies by specializing in Gastric & Mixed Tumors at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center in 1994. Dr. med. Klaus also undertook studies at Cornell University and the University of Cape Town during unspecified periods.

In 2008, Dr. Rensing pursued a Master of Business Administration (MBA) degree at The Berlin School of Economics and Law, which they completed in 2010. Lastly, they obtained the Facharzt für Gynäkologie & Geburtshilfe degree in Obstetrics & Gynecology from UKM - Universitätsklinikum Münster from 2000 to 2009.

Overall, Dr. med. Klaus Rensing has a diverse educational background with degrees in Medicine, a Ph.D., and an MBA.